Indeterminate acute liver failure: A riddle wrapped in a mystery inside an enigma
โ Scribed by Timothy J. Davern
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 461 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
Fulminant hepatitis of unknown origin remains a significant cause of mortality, for which liver transplantation is often considered as the only therapeutic option. In retrospective studies, human herpesvirus 6 (HHV-6) infections have been associated with such diseases, but the diagnosis of HHV-6 infection of the liver is rarely established during the acute phase of liver failure. Using real-time polymerase chain reaction (PCR), we diagnosed two cases of severe acute liver failure (ALF) related to HHV-6 occurring in immunocompetent young adults. Both cases had a favourable outcome, one after valganciclovir therapy and one after liver transplantation associated with ganciclovir. Viral origin was evidenced in each case by the detection of high amounts of HHV-6 DNA in liver tissue by the PCR assay. The decrease of intrahepatic viral load after therapeutic intervention was also monitored by quantitative PCR and paralleled in the two cases the clinical improvement. Diagnosis of HHV-6 infection must be systematically evoked in case of unexplained ALF, since it might lead to specific therapeutic interventions, in addition to liver transplantation.
๐ SIMILAR VOLUMES
Intro; Title Page; Copyright; Contents; Disclaimer; Acknowledgements; Dedication; Book One; Chapter One: A Scion is Born; Chapter Two: The Making of a Horseman; Chapter Three: Coming of Age; Chapter Four: Discovery; Chapter Five: A Little Problem; Chapter Six: A Life-Changing Day; Chapter Seven: The
The realization in the 1980s that liver transplantation was feasible in acute liver failure created a need for prognostic indicators to determine the subset of patients most likely to benefit from that intervention. Although many clinical and investigational parameters have been shown to reflect pro
Mortality of fulminant hepatic failure with standard supportive therapy is high (80 to 85%), but unfortunately most patients present to hospital already in Grade IV encephalopathy with severe liver dysfunction, and many have secondary organ damage. If seen earlier, during Grade III encephalopathy, r
Acute liver failure (ALF) is characterized by rapid progressive organ failure and poor outcome. The pathophysiology of multiorgan dysfunction in ALF remains unclear but increased systemic inflammatory response is believed to be an important determining factor. Asymmetric dimethylarginine (ADMA), an